Altimmune Inc (NASDAQ:ALT)
| 1.83 Delayed Data As of 3:59pm ET |  -0.01 / -0.54%Today’s Change | 1.51 Today|||52-Week Range 5.94 | -11.17% Year-to-Date |
Latest ALT News | Press Releases
No recent news for Altimmune Inc.
Today’s Trading
| Previous close | 1.84 |
| Today’s open | 1.85 |
| Day’s range | 1.81 - 1.90 |
| Volume | 64,142 |
| Average volume (3 months) | 126,584 |
| Market cap | $29.1M |
Data as of 3:59pm ET, 12/10/2019
Growth & Valuation
| Earnings growth (last year) | +87.40% |
| Earnings growth (this year) | +94.13% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -3.79% |
| P/E ratio | 1.9 |
| Price/Sales | 0.56 |
| Price/Book | 0.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BNGOBionano Genomics Inc | -0.04 | -3.70% |
| APVOAptevo Therapeutics ... | +0.01 | +2.22% |
| SAVACassava Sciences Inc | -0.02 | -1.20% |
| IGCIndia Globalization ... | -0.02 | -2.99% |
Data as of 6:30pm ET, 12/10/2019
Financials
| Next reporting date | March 25, 2020 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $10.3M |
| Annual profit (last year) | -$39.2M |
| Net profit margin | -379.16% |
Profile
Sector Commercial Services |
Industry Miscellaneous Commercial Services |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
